Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia

被引:134
作者
Nishizawa, H.
Pryor-Koishi, K.
Kato, T.
Kowa, H.
Kurahashi, H.
Udagawa, Y.
机构
[1] Fujita Hlth Univ, Dept Obstet & Gynecol, Toyoake, Aichi 4701192, Japan
[2] Fujita Hlth Univ, COE Program Century 21, Dev Ctr Targeted & Minimally Invas Diag & Treatme, Toyoake, Aichi 4701192, Japan
[3] Fujita Hlth Univ, Div Mol Genet, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan
关键词
microarray analysis; gene ontology; pre-eclampsia;
D O I
10.1016/j.placenta.2006.05.010
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although it has been well documented that pre-eclampsia is caused by a combination of maternal and fetal susceptibility genes, little is known about the precise etiology of this complicated disorder. To investigate how the expression of fetal genes contributes to the mechanisms underlying the progression of this disease, we have analyzed differentially expressed genes using placentas from 13 normal pregnancies and 14 pregnancies with severe pre-eclampsia. We performed genome-wide expression profiling using high-density oligonucleotide microarrays, followed by validation using real-time PCR. Among the 47,000 genes that were screened in the microarray, 137 genes were found to be differentially expressed between normal and pre-eclamptic tissues. Among these candidates, 70 were up-regulated and 67 were down-regulated. The up-regulated genes included leptin and inhibin A, which are well-known biological markers for pre-eclampsia, as well as FLT1, which was recently proved to be tightly linked with the etiology of this disease. Gene ontology analysis further revealed several biological processes that could be associated with the development of pre-eclampsia, including response to stress, host-pathogen interactions, lipid metabolism, and carbohydrate metabolism. Analyses of biological mechanisms highlighted some important pathways that may be involved in this disorder, such as the TGF-beta and CEBPA-related pathways. Furthermore, when our present subjects were classified as either severe cases of early onset or late onset pre-eclampsia, the expression of I I genes could be correlated with the severity of this disorder. These genes may therefore prove to be novel biological markers by which the severity of this condition could be predicted. Our data are likely to be a useful future resource in the elucidation of the disease-process and in the identification of novel markers for pre-eclampsia. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:487 / 497
页数:11
相关论文
共 33 条
[1]   Implantation: Can immunological parameters of implantation failure be of interest for preeclampsia? [J].
Chaouat, G ;
Ledee-bataille, N ;
Zoubas, S ;
Dubanchet, S ;
Sandra, O ;
Martal, J ;
Ostojojic, S ;
Frydman, R .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2003, 59 (02) :205-217
[2]   Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro [J].
Donker, RB ;
Asgeirsdóttir, SA ;
Gerbens, F ;
van Pamus, MG ;
Kallenberg, CGM ;
Meerman, GJT ;
Aarnoudse, JG ;
Molema, G .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) :98-106
[3]   Preeclampsia:: increased expression of soluble ADAM 12 [J].
Gack, S ;
Marmé, A ;
Marmé, F ;
Wrobel, G ;
Vonderstrass, B ;
Bastert, G ;
Lichter, P ;
Angel, P ;
Schorpp-Kistner, M .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11) :887-896
[4]   Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy [J].
Gifford, RW ;
August, PA ;
Cunningham, G ;
Green, LA ;
Lindheimer, MD ;
McNellis, D ;
Roberts, JM ;
Sibai, BM ;
Taler, SJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (01) :S1-S22
[5]  
GOPEC Consortium, 2005, AM J HUM GENET, V77, P127
[6]   Expectant management of early onset, severe pre-eclampsia:: Perinatal outcome [J].
Hall, DR ;
Odendaal, HJ ;
Kirsten, GF ;
Smith, J ;
Grové, D .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (10) :1258-1264
[7]   Expectant management of early onset, severe pre-eclampsia:: Maternal outcome [J].
Hall, DR ;
Odendaal, HJ ;
Steyn, DW ;
Grové, D .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (10) :1252-1257
[8]   Advanced molecular techniques in pregnancy research: Proteomics and genomics - A workshop report [J].
Kalionis, B ;
Moses, E .
PLACENTA, 2003, 24 :S119-S122
[9]   Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia [J].
Kudo, Y ;
Boyd, CAR ;
Sargent, IL ;
Redman, CWG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) :719-726
[10]   Circulating angiogenic factors and the risk of preeclampsia [J].
Levine, RJ ;
Maynard, SE ;
Qian, C ;
Lim, KH ;
England, LJ ;
Yu, KF ;
Schisterman, EF ;
Thadhani, R ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :672-683